CD4 and myeloid sarcoma: The pathogenesis of MS involves dysregulated TReg cells [33,34,35,36], increased TFH activity [37], recruitment of proinflammatory CD4+ T cells to the CNS [31], accumulation of CD8+ T cells in CNS lesions [38], and increased concentration of soluble CD25 in sera [39].